2024-04-01 15:47 | CC:FRX | Fennec Pharmaceuticals Inc | 15.10 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
2024-04-01 15:05 | CC:FRX | Fennec Pharmaceuticals Inc | 15.10 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-04-01 13:28 | CC:FRX | Fennec Pharmaceuticals Inc | 15.10 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-21 09:50 | CC:FRX | Fennec Pharmaceuticals Inc | 13.18 | News Release200 | Fennec loses $16.04-million (U.S.) in 2023 |
2024-03-19 09:27 | CC:FRX | Fennec Pharmaceuticals Inc | 13.18 | News Release200 | Fennec to release fiscal 2023 results March 21 |
2024-03-18 02:32 | CC:FRX | Fennec Pharmaceuticals Inc | 13.18 | News Release200 | Fennec enters Pedmarqsi licensing deal with Norgine |
2024-02-29 12:24 | CC:FRX | Fennec Pharmaceuticals Inc | 12.89 | News Release200 | Fennec expects revenue of $20.7M to $21.2M for 2023 |
2024-02-01 09:29 | CC:FRX | Fennec Pharmaceuticals Inc | | News Release200 | Fennec notes FDA reminder re Pedmark non-substitution |
2023-12-05 09:27 | CC:FRX | Fennec Pharmaceuticals Inc | 12.55 | News Release200 | Fennec closes $5-million investment from Petrichor |
2023-11-10 17:44 | CC:FRX | Fennec Pharmaceuticals Inc | 10.75 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-10 17:43 | CC:FRX | Fennec Pharmaceuticals Inc | 10.75 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-06 11:15 | CC:FRX | Fennec Pharmaceuticals Inc | 10.96 | News Release200 | Fennec loses $1.86-million (U.S.) in Q3 2023 |
2023-10-30 12:26 | CC:FRX | Fennec Pharmaceuticals Inc | 9.64 | News Release200 | Fennec Pharmaceuticals to release Q3 results Nov. 6 |
2023-08-08 14:47 | CC:FRX | Fennec Pharmaceuticals Inc | 10.63 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-03 09:59 | CC:FRX | Fennec Pharmaceuticals Inc | 10.63 | News Release200 | Fennec Pharmaceuticals loses $5.44-million (U.S.) in Q2 |
2023-07-31 12:59 | CC:FRX | Fennec Pharmaceuticals Inc | 11.27 | News Release200 | Fennec Pharmaceuticals to release Q2 results Aug. 3 |
2023-06-12 17:16 | CC:FRX | Fennec Pharmaceuticals Inc | 11.65 | News Release200 | Fennec Pharmaceuticals holders approve AGM resolutions |
2023-06-06 09:44 | CC:FRX | Fennec Pharmaceuticals Inc | 11.51 | News Release200 | Fennec receives Pedmarqsi marketing OK by EU Commission |
2023-06-01 13:35 | CC:FRX | Fennec Pharmaceuticals Inc | 10.25 | SEDAR MD & A815 | SEDAR MD & A |
2023-06-01 13:29 | CC:FRX | Fennec Pharmaceuticals Inc | 10.25 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-11 10:00 | CC:FRX | Fennec Pharmaceuticals Inc | 10.67 | News Release200 | Fennec Pharmaceuticals loses $6.05-million (U.S.) in Q1 |
2023-05-08 11:37 | CC:FRX | Fennec Pharmaceuticals Inc | 10.98 | News Release200 | Fennec to release Q1 2023 results May 11 |